Trial intelligence / Profile preview

VSE-2: Vasopressin, Epinephrine, and Corticosteroids for Inhospital Cardiac Arrest

NCT00729794Phase 3Completed

Sponsor
National and Kapodistrian University of Athens
Start
Sep 2008
Primary completion
Nov 2010
Modality
Peptides, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of vasopressin, methylprednisolone, hydrocortisone in cardiac arrest (SCA), sponsored by National and Kapodistrian University of Athens. Started Sep 2008; status: completed.

02

Drugs

vasopressinmethylprednisolonehydrocortisone
03

Conditions

cardiac arrest (SCA)

Beyond the preview

Go deeper on NCT00729794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00729794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call